Related Experiment Video
Updated: Jun 17, 2026
07:20
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
[A novel formulation of cisplatin (CDDP)]
Akio Sugitachi1, Yusuke Kimura, Tetsuya Itabashi
1Department of Surgery, Iwate Medical University.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|December 29, 2009
Summary
This study introduces novel CDDP delivery systems using deacetylated chitin. These systems show promising targeting and sustained release, effectively inhibiting cancer cell growth for chemotherapy.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Oncology
Context:
- Developing effective drug delivery systems is crucial for cancer chemotherapy.
- Targeted delivery and sustained release of anticancer agents can improve therapeutic outcomes and reduce side effects.
- Chitin derivatives offer potential as biocompatible carriers for drug delivery applications.
Purpose:
- To evaluate a newly devised CDDP delivery system utilizing 70% deacetylated chitin.
- To assess the targeting potential and sustained release characteristics of the CDDP delivery system.
- To examine the in vitro anticancer activity of CDDP released from the novel delivery systems against human gastric cancer cells (MKN-45).
Summary:
- Two types of CDDP delivery systems (A and B) were prepared using deacetylated chitin.
- Ex vivo studies demonstrated favorable targeting properties, with increased adhesive force at 37°C compared to 25°C.
- In vitro studies confirmed sustained CDDP release and significant growth suppression activity against MKN-45 cells.
Impact:
- The developed CDDP delivery systems exhibit promising targeting and sustained release capabilities.
- These systems show potential for enhanced cancer chemotherapy by effectively inhibiting cancer cell growth.
- The findings suggest a novel approach for improving the efficacy of cisplatin-based cancer treatments.
